Related Experiment Video
Updated: Jul 2, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Machine Learning Application for Medicinal Chemistry: Colchicine Case, New Structures, and Anticancer Activity
Damian Nowak1, Adam Huczyński2, Rafał Adam Bachorz3,4
1Department of Quantum Chemistry, Faculty of Chemistry, Adam Mickiewicz University in Poznan, Uniwersytetu Poznanskiego 8, 61-614 Poznan, Poland.
Machine learning models were developed to predict anticancer activity of colchicine compounds, identifying new drug candidates. This approach aids in discovering novel therapeutics by forecasting efficacy and guiding drug design.
Area of Science:
- Computational Chemistry
- Medicinal Chemistry
- Machine Learning in Drug Discovery
Background:
- Traditional quantitative structure-activity relationship (QSAR) methods are enhanced by machine learning (ML) for drug discovery.
- Colchicine derivatives are explored for their anticancer potential.
- Predictive modeling is crucial for identifying effective and safe drug candidates.
Purpose of the Study:
- To assess the anticancer potential of colchicine-based compounds across five cell lines.
- To develop ML models for predicting anticancer activity (IC50 values) and generating novel compounds.
- To compute resistance index (RI) and selectivity index (SI) for drug resistance and safety evaluation.
Main Methods:
- Utilized various ML algorithms including random forest, decision tree, support vector machines, k-nearest neighbors, and multiple linear regression.
- Assessed inhibitory capabilities against five cancer cell lines.
- Developed a novel ML system to recommend new chemical structures based on known anticancer activity.
Main Results:
- Established a library of novel colchicine-based compounds with predicted IC50 values.
- Developed a validated predictive ML model capable of estimating IC50 values from molecular structures.
- Identified promising colchicine derivatives with potential anticancer activity.
Conclusions:
- Machine learning effectively predicts anticancer activity and aids in the design of novel colchicine-based compounds.
- The developed predictive model provides a reliable tool for estimating drug efficacy based on molecular structure.
- This study facilitates the discovery of new anticancer agents with improved therapeutic profiles.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Discovery: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Destabilize Microtubules
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...